Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 101048 |
Drug Identification Number | 02362619 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 2.00G 0.25G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-12-16 |
Estimated end date | 2020-02-01 |
Actual end date | 2020-01-21 |
Shortage status | Resolved |
Updated date | 2020-01-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-01-22 | English | Compare |
v6 | 2020-01-21 | French | Compare |
v5 | 2020-01-21 | English | Compare |
v4 | 2019-12-17 | English | Compare |
v3 | 2019-12-11 | French | Compare |
v2 | 2019-12-11 | English | Compare |
v1 | 2019-12-11 | English | Compare |
Showing 1 to 7 of 7